How Digital Health Technologies have been Used to Support Regulatory Drug Approval.

Thierry A, Manson A, Podhaisky HP

Open source

DOI
10.1007/s43441-026-01020-z
Published
2026 Nov
Container
Therapeutic innovation & regulatory science
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s43441-026-01020-z,
  title = {How Digital Health Technologies have been Used to Support Regulatory Drug Approval.},
  author = {Thierry A and Manson A and Podhaisky HP},
  year = {2026},
  journal = {Therapeutic innovation \& regulatory science},
  doi = {10.1007/s43441-026-01020-z},
  url = {https://doi.org/10.1007/s43441-026-01020-z}
}

RIS

TY  - JOUR
TI  - How Digital Health Technologies have been Used to Support Regulatory Drug Approval.
AU  - Thierry A
AU  - Manson A
AU  - Podhaisky HP
PY  - 2026
JO  - Therapeutic innovation & regulatory science
DO  - 10.1007/s43441-026-01020-z
UR  - https://doi.org/10.1007/s43441-026-01020-z
ER  - 

APA

A, T., A, M., & HP, P. (2026). How Digital Health Technologies have been Used to Support Regulatory Drug Approval.. Therapeutic innovation & regulatory science. https://doi.org/10.1007/s43441-026-01020-z

Source records